| |
| |
|
| Insider
Information: |
Morrow George J |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
164,177 |
|
|
Indirect Shares
|
5,990 |
|
|
| Direct
Value |
$41,537,825 |
|
|
|
Indirect Value
|
$1,695,313 |
|
|
| Total
Shares |
170,167 |
|
|
| Total
Value |
$43,233,138 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 18.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
Exe VP, Global Commerc... |
2010-04-29 |
130,488 |
2010-04-29 |
2,717 |
Premium* |
|
|
Align Technology Inc |
ALGN |
|
2024-05-17 |
2,143 |
2024-05-17 |
3,273 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2011-05-12 |
0 |
Premium* |
|
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Director |
2015-05-21 |
27,347 |
2012-10-15 |
0 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-05-17 |
4,199 |
2024-03-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMGN |
Amgen Inc |
Exe VP, Global Commercial Ops |
• – – |
2010-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
133,290 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Global Commercial Ops |
• – – |
2010-04-28 |
4 |
D |
$57.84 |
$81,034 |
D/D |
(1,401) |
131,889 |
0 |
- |
|
| AMGN |
Amgen Inc |
Exe VP, Global Commercial Ops |
• – – |
2010-04-29 |
4 |
D |
$58.18 |
$81,510 |
D/D |
(1,401) |
130,488 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2010-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
14,000 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2011-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
17,000 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2011-08-05 |
4 |
B |
$15.79 |
$157,900 |
D/D |
10,000 |
12,500 |
2.39 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2012-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
15,000 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2012-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
20,000 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
• • – |
2012-07-30 |
4 |
D |
$14.25 |
$59,366 |
D/D |
(4,166) |
10,834 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
• • – |
2012-07-30 |
4 |
D |
$14.25 |
$154,385 |
D/D |
(10,834) |
0 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2012-10-15 |
4 |
B |
$0.01 |
$64 |
D/D |
6,394 |
6,394 |
2.31 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2013-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,700 |
27,700 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2013-05-23 |
4 |
B |
$0.01 |
$60 |
D/D |
5,953 |
12,347 |
2.31 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2013-10-22 |
4 |
OE |
$8.33 |
$624,750 |
D/D |
75,000 |
102,700 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2013-10-22 |
4 |
S |
$56.61 |
$4,295,289 |
D/D |
(75,000) |
27,700 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2014-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,700 |
35,400 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
19,847 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2015-05-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,500 |
40,900 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
27,347 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2016-05-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,500 |
46,400 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2016-05-23 |
4 |
OE |
$11.81 |
$875,850 |
D/D |
50,000 |
96,400 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2016-05-23 |
4 |
S |
$77.72 |
$3,885,760 |
D/D |
(50,000) |
46,400 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2017-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
51,400 |
0 |
- |
|
| ALGN |
Align Technology Inc |
Director |
– • – |
2018-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,115 |
54,515 |
0 |
- |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
